LONG-TERM SURVIVAL OF PATIENTS WITH BREAST-CANCER - STUDY OF THE CURABILITY OF THE DISEASE

被引:185
作者
LANGLANDS, AO
POCOCK, SJ
KERR, GR
GORE, SM
机构
[1] ROYAL FREE HOSP,SCH MED,DEPT CLIN EPIDEMIOL & SOCIAL MED,LONDON NW3 2PN,ENGLAND
[2] ROYAL INFIRM EDINBURGH,DEPT RADIOTHERAPY,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND
[3] WESTERN GEN HOSP,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
[4] UNIV ABERDEEN,DEPT STAT,ABERDEEN AB9 1AS,SCOTLAND
关键词
D O I
10.1136/bmj.2.6200.1247
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A retrospective analysis was made of 3878 cases of breast carcinoma first seen in Edinburgh from 1954 to 1964. During this time there was a policy to treat breast cancer by simple mastectomy and x-ray therapy, and over 90% of cases classified as international stages I and II were so treated. The mortality in these women was compared with that in an equivalent normal population using Scottish national age-specific death rates. For every year of follow-up within 20 years of initial treatment there was an excess mortality from all causes. There was an overall excess mortality of 58% among patients with breast cancer 15–20 years after initial treatment, and 20 times more deaths occurred in this period from breast cancer than in a normal population. For patients disease-free after 15 years there was still a 28% excess mortality from all causes. Factors known to be of major prognostic significance for five-year survivorship had less influence than might have been expected when the ratio of observed to expected deaths was considered for longer periods of follow-up. The effect of clinical staging (I, II, or III), though initially marked, largely disappeared by the 10th year of follow-up, and after allowing for age there was no evidence beyond 10 years of an effect on survival of the original stage of the disease. Similarly, the effect of tumour size on survival disappeared after 10 years. Women who were premenopausal at presentation still had a significant excess of deaths in the fourth quinquennium of follow-up. In the menopausal and postmenopausal groups combined there was still a small non-significant excess of deaths from all causes after 15 years but this almost disappeared when patients who had already relapsed were excluded. In terms of overall mortality only patients who have undergone the menopause before presentation and who are disease-free 15 years after primary treatment may prove to be cured by conventional techniques such as simple mastectomy and postoperative radiotherapy. © 1979, British Medical Journal Publishing Group. All rights reserved.
引用
收藏
页码:1247 / 1251
页数:5
相关论文
共 28 条
[1]  
BOND WH, 1968, P S TREATMENT CARCIN
[2]   ANALYSIS OF SURVIVAL DATA UNDER PROPORTIONAL HAZARDS MODEL [J].
BRESLOW, NE .
INTERNATIONAL STATISTICAL REVIEW, 1975, 43 (01) :45-58
[3]  
Brinkley D, 1977, World J Surg, V1, P287
[4]  
BRINKLEY D, 1975, LANCET, V2, P95
[5]   OBSERVATIONS ON MORTALITY FROM CARCINOMA OF BREAST [J].
CAMPOS, JL .
BRITISH JOURNAL OF RADIOLOGY, 1972, 45 (529) :31-&
[6]  
CUTLER SJ, 1967, J NATL CANCER I, V39, P193
[7]   ADJUSTMENT OF LONG-TERM SURVIVAL RATES FOR DEATHS DUE TO INTERCURRENT DISEASE [J].
CUTLER, SJ ;
AXTELL, LM ;
SCHOTTENFELD, D .
JOURNAL OF CHRONIC DISEASES, 1969, 22 (6-7) :485-+
[8]  
CUTLER SJ, 1970, CANCER, V26, P938, DOI 10.1002/1097-0142(197010)26:4<938::AID-CNCR2820260431>3.0.CO
[9]  
2-K
[10]   CURABILITY OF BREAST-CANCER [J].
DUNCAN, W ;
KERR, GR .
BRITISH MEDICAL JOURNAL, 1976, 2 (6039) :781-783